Loading...
XPAR
GDS
Market cap1.41bUSD
Jul 10, Last price  
11.20EUR
1D
0.90%
1Q
8.74%
Jan 2017
-23.32%
IPO
-39.65%
Name

Ramsay Generale de Sante SA

Chart & Performance

D1W1MN
XPAR:GDS chart
P/E
P/S
0.24
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
6.95%
Revenues
5.24b
+4.70%
1,435,500,0001,741,500,0001,906,000,0001,983,800,0002,046,200,0001,926,100,0001,955,000,0001,928,600,0001,869,700,0001,711,600,0002,226,900,0002,234,400,0002,241,500,0003,401,100,0003,746,200,0004,022,600,0004,301,000,0004,701,500,0005,006,500,0005,242,000,000
Net income
-54m
L+0.37%
40,900,000225,400,00045,600,00087,200,00042,400,00037,900,000-28,500,00055,700,000111,300,00019,700,00036,900,00057,000,0007,300,00015,300,00018,700,00065,000,000118,400,00049,400,000-53,900,000-54,100,000
CFO
694m
+18.22%
154,900,000152,600,000179,600,000253,300,000149,000,000194,100,000172,400,000206,700,000151,300,000159,000,000196,000,000209,400,000213,900,000213,600,000729,600,000652,300,000262,500,000598,900,000586,800,000693,700,000
Dividend
Dec 02, 20140.79134 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ramsay Générale de Santé S.A., headquartered in Paris, France, manages a network of hospitals across the nation. These facilities provide a wide spectrum of healthcare services, including specialized care in anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity management, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology. Furthermore, they conduct various surgical procedures such as thoracic, vascular, and endovascular interventions. Founded in 1987, the company adopted its current name in December 2015, having previously been known as Générale de Santé SA. Ramsay Générale de Santé S.A. functions as a subsidiary of Ramsay Health Care Limited.
IPO date
Jun 19, 2001
Employees
36,000
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT